Yüklüyor......
P04.12 The preclinical efficacy study using mesenchymal stem cells expressing TRAIL & CD for glioblastoma.
BACKGROUND: Our previous study using mesenchymal stem cells (MSCs) as delivery vehicles for tumor necrosis factor-related apoptosis inducing ligand (TRAIL) showed an anti-tumor effect in vitro and in vivo for glioblastoma. However, because most malignant glioma cells exhibit TRAIL resistance, we nee...
Kaydedildi:
| Yayımlandı: | Neuro Oncol |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6144671/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.246 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|